Algeta ASA : Changes in Algeta's Financial Calendar 2013

Marketwired

OSLO, NORWAY--(Marketwired - May 15, 2013) -

Algeta ASA (OSE: ALGETA), a company focused on thedevelopment of novel targeted cancer therapeutics, announces changes to itsfinancial calendar for 2013.

New dates are as follows:

2(nd) Quarter Results 2013: 28 August 2013

3(rd) Quarter Results 2013: 6 November 2013

All dates are tentative and could be subject to change.

About Algeta

Algeta is a company focused on developing novel targeted therapies forpatientswith cancer based on its alpha-pharmaceutical platform. TheCompany isheadquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,based inCambridge, MA performing commercial marketing operations in the US.Algeta islisted on the Oslo Stock Exchange (ALGETA.OL). For more informationpleasevisit www.algeta.com.

Press release:http://hugin.info/134655/R/1701819/562060.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE

[HUG#1701819]

Contact:
For further information, please contact

Mike Booth
Communications & Corporate Affairs
+47 2202 4510
Email Contact

Media enquiries:

Mark Swallow
Citigate Dewe Rogerson
+44 207 638 9571
Email Contact

Knut Ekern
Gambit Hill & Knowlton
+47 22 04 82 00
Email Contact

Kari Watson
MacDougall Biomedical Communications
+1 781 235 3060
Email Contact

US investor enquiries:

Tricia Swanson
The Trout Group
+1 646 378 2953
Email Contact

Rates

View Comments (0)